Clinical Trial: Study to Assess the Efficacy and Safety of Rina-S in Participants With Advanced Gastrointestinal (GI) Cancers

U.S., April 21 -- ClinicalTrials.gov registry received information related to the study (NCT07539311) titled 'Study to Assess the Efficacy and Safety of Rina-S in Participants With Advanced Gastrointestinal (GI) Cancers' on April 13.

Brief Summary: This Phase 2 study will be conducted in different countries around the world with up to about 160 participants.

The purpose of this study is to evaluate how well Rina-S works against GI cancers.

The medication in this study is Rina-S monotherapy (by itself; no other cancer treatments). All participants will receive active drug; no one will be given placebo.

Participation in the study will require visits to the study site(s). During site visits, there will be various tests (such as blood draws...